M
Meds
Online pharmacy that offers and sells prescription and prescription drugs with permission from the Swedish Medicines Agency
About Meds
MEDS.se is an online pharmacy that provides a comprehensive range of healthcare products, prescription medications, and wellness items. The company primarily serves individual consumers who seek convenience and accessibility in purchasing medical and wellness products. Operating in the e-commerce and healthcare market, MEDS.se leverages a digital platform to offer a variety of products including over-the-counter medications, prescription drugs, skincare products, and nutritional supplements.
The business model of MEDS.se is based on direct-to-consumer sales through its online platform. Revenue is generated through the sale of these products, often at competitive prices, and the company frequently offers discounts and promotions to attract and retain customers. MEDS.se also emphasizes fast and reliable delivery services, ensuring that customers receive their orders promptly.
By focusing on a user-friendly online shopping experience, a broad product range, and efficient delivery, MEDS.se aims to meet the healthcare needs of its customers in a convenient and accessible manner.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Stockholm, Sweden
- Employees
- 83
- Open positions
- 1
- Dealroom signal
- 66.2/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Pharmacy, Tech for Patients, Nordic Rising Star 2022, Hard Tech, Woman Founder, Digital Care
- Business model
- Marketplace & ecommerce
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| IPOOther financing | Sep 2025 | $31M | $121M | Undisclosed | ↗ |
| SECONDARYOther financing | Sep 2025 | $0 | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Meds is 2.1M monthly website visits, up 10.5% over the last three months. Meds's team declined 1.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Inbox Capital- MAM2 Asset Management AB
Other known investors4 additional known investors
Carl Jansson
Centripetal AB
Club Network Investments (CNI)- MWMartin W.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Meds on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Meds’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.